Stocktoria
Vivos Therapeutics, Inc. VVOS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-12-11
Vivos Therapeutics, Inc. statistics & valuation
Market cap$7.6M
P / S0.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 60.4% | 60.0% | 59.9% | 62.5% | 74.6% |
| Operating margin | -114.1% | -74.3% | -125.3% | -156.2% | -120.7% |
| Net margin | -121.4% | -74.1% | -98.4% | -148.8% | -120.2% |
| FCF margin | -100.9% | -88.2% | -92.4% | -128.0% | -107.4% |
| Return on assets | -84.2% | -72.9% | -126.6% | -173.8% | -60.2% |
| Return on equity | 1365.8% | -140.0% | -3304.9% | -496.7% | -79.4% |
| Debt / equity | -0.49× | — | — | — | 0.05× |
| Current ratio | 0.24 | 1.50 | 0.34 | 0.80 | 3.64 |
| Revenue growth | 16.0% | 8.9% | -13.9% | -5.1% | 29.2% |
Source: SEC EDGAR filings · CIK 0001716166 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.